Alexander Kautzky

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF AFFECTIVE DISORDERS. 2026;393(Pt A):120353
Ten-year working life sequences in women and men following sickness absence due to common mental disorders: A Swedish prospective cohort study
Kautzky A; Virtanen M; Alexanderson K; Mittendorfer-Rutz E; Gemes K
Journal article: CANCER MEDICINE. 2025;14(19):e71263
Exploring the Influence of Sex and Gender on Cancer: A Comprehensive Analysis
Gisinger T; Kautzky-Willer A; Kautzky A
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025;98:26-34
Clinical predictors of treatment resistant depression
Serretti A; Kasper S; Bartova L; Zohar J; Souery D; Montgomery S; Ferentinos P; Rujescu D; Kautzky A; Attanasio F; Zanardi R; Fabbri C; Baune BT; Ferri R; Mendlewicz J
Journal article: ARCHIVES OF REHABILITATION RESEARCH AND CLINICAL TRANSLATION. 2025;:100516
Post-COVID rehabilitation outcomes: a comparative cohort study
Prüfer F; Kautzky A; Unger A; Matko Š; Fischer MJ; Zwick RH; Grote V
Journal article: SCIENTIFIC REPORTS. 2025;15(1):20635
Brain glutamate and gamma-aminobutyric acid levels across COVID-19 lockdowns in patients with recurrent major depressive disorder and healthy individuals
Popper V; Spurny-Dworak B; Unterholzner J; Reed M; Wechsler T; Kautzky A; Stoehrmann P; Kloebl M; Muehlberger A; Frey R; Rujescu D; Lanzenberger R; Vanicek T
Article: JOURNAL OF AFFECTIVE DISORDERS. 2025;379:822-834
Working life patterns after sickness absence due to depression: A 15-year register-based prospective cohort study
Stutaite G; Mittendorfer-Rutz E; Helgesson M; Kautzky A; Finnes A; Gemes K
Journal article: EUROPEAN PSYCHIATRY. 2025;68(1):e61
Symptom networks in major depressive disorder and treatment response: special focus on TRD
Kautzky A; Bartova L; Dold M; Souery D; Montgomery S; Zohar J; Mendlewicz J; Fabbri C; Serretti A; Tretiakov E; Rujescu D; Harkany T; Kasper S
Article: BIPOLAR DISORDERS. 2025;27(3):192-204
Treatment Patterns for Incident Bipolar Disorder Among Nonrefugee Immigrants, Refugees, Second-Generation Immigrants, and Host Population in Sweden
Kautzky A; Pettersson E; Amin R; Akhtar A; Tanskanen A; Taipale H; Wancata J; Gemes K; Mittendorfer-Rutz E
Article: ECLINICALMEDICINE. 2025;81:103108
Machine learning-based mortality risk assessment in first-episode bipolar disorder: a transdiagnostic external validation study
Lieslehto J; Tiihonen J; Lahteenvuo M; Kautzky A; Akhtar A; Armannsdottir B; Leucht S; Correll CU; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Article: PSYCHOLOGICAL MEDICINE. 2024;54(16):1-11
Labor market marginalization in individuals with bipolar disorder: a Swedish nationwide register-based sibling comparison study
Armannsdottir B; Taipale H; Akhtar A; Kautzky A; Bjorkenstam E; Lieslehto J; Tiihonen J; Amin R; Mittendorfer-Rutz E
Article: NUTRIENTS. 2024;16(16):2584
The Effects of Caloric Restriction and Clinical Psychological Intervention on the Interplay of Gut Microbial Composition and Stress in Women
Bellach L; Kautzky-Willer A; Heneis K; Leutner M; Kautzky A
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024;84:59-68
The clinical perspective on late-onset depression in European real-world treatment settings
Bartova L; Fugger G; Dold M; Kautzky A; Bairhuber I; Kloimstein P; Fanelli G; Zanardi R; Weidenauer A; Rujescu D; Souery D; Mendlewicz J; Zohar J; Montgomery S; Fabbri C; Serretti A; Kasper S
Article: BIOLOGY OF SEX DIFFERENCES. 2024;15(1):36
Sex differences of post-Covid patients undergoing outpatient pulmonary rehabilitation
Kautzky A; Nopp S; Gattinger D; Petrovic M; Antlinger M; Schomacker D; Kautzky-Willer A; Zwick RH
Article: NPJ DIGITAL MEDICINE. 2024;7(1):56
Unraveling cradle-to-grave disease trajectories from multilayer comorbidity networks
Dervic E; Sorger J; Yang L; Leutner M; Kautzky A; Thurner S; Kautzky-Willer A; Klimek P
Article: TRANSLATIONAL PSYCHIATRY. 2024;14(1):42
Effects of lockdowns on neurobiological and psychometric parameters in unipolar depression during the COVID-19 pandemic
Unterholzner J; Kautzky A; Reed MB; Wechsler TF; Popper V; Spurny-Dworak B; Stoehrmann P; Kloebl M; Varghese N; Muehlberger A; Eckert A; Frey R; Rujescu D; Lanzenberger R; Vanicek T
Journal article: NEUROSCIENCE APPLIED. 2024;3:104425
Individualized machine learning-based mortality risk assessment in first-episode bipolar disorder: a transdiagnostic external validation study
Lieslehto J; Tiihonen J; Lähteenvuo M; Kautzky A; Akhtar A; Ármannsdóttir B; Leucht S; Correll C; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;335:349-357
Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database
Kraus C; Kautzky A; Watzal V; Gramser A; Kadriu B; Deng Z-D; Bartova L; Lanzenberger R; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fanelli G; Serretti A; Kasper S
Article: HELIYON. 2023;9(7):e17570
Diabetes incidence in Austria: The role of famines on diabetes and related NCDs
Kaleta M; Leutner M; Thurner S; Kautzky A; Endel G; Kiss N; Robausch M; Kautzky-Willer A; Klimek P
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;332:105-114
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
Bartova L; Fugger G; Dold M; Kautzky A; Fanelli G; Zanardi R; Albani D; Weidenauer A; Rujescu D; Souery D; Mendlewicz J; Montgomery S; Zohar J; Fabbri C; Serretti A; Kasper S
Article: TRANSLATIONAL PSYCHIATRY. 2023;13(1):175
Obesity as pleiotropic risk state for metabolic and mental health throughout life
Leutner M; Dervic E; Bellach L; Klimek P; Thurner S; Kautzky A
Article: EUROPEAN PSYCHIATRY. 2023;66(1):e35
Age as a moderating factor of treatment resistance in depression
Kautzky A; Bartova L; Fugger G; Dold M; Souery D; Montgomery S; Zohar J; Mendlewicz J; Fabbri C; Serretti A; Rujescu D; Kasper S
Article: HELIYON. 2023;9(4):e15377
Systematic population-wide ecological analysis of regional variability in disease prevalence
Lo Sardo DR; Thurner S; Sorger J; Heiler G; Gyimesi M; Kautzky A; Leutner M; Kautzky-Willer A; Klimek P
Article: BIOMEDICINE & PHARMACOTHERAPY. 2023;158:114089
Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies
Leutner M; Butylina M; Matzhold C; Klimek P; Cuhaj C; Bellach L; Baumgartner-Parzer S; Reiter B; Preindl K; Kautzky A; Stimpfl T; Thurner S; Pietschmann P; Fuernsinn C; Kautzky-Willer A
Journal article: NEUROSCIENCE APPLIED. 2023;2:102444
Machine learning model to estimate mortality risk after the first episode of bipolar disorder
Lieslehto J; Tiihonen J; Lähteenvuo M; Kautzky A; Akhtar A; Ármannsdóttir B; Leucht S; Correll C; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Article: WIENER KLINISCHE WOCHENSCHRIFT. 2023;135(SUPPL 1):225-236
Mental disorders and diabetes mellitus (Update 2023)
Abrahamian H; Kautzky-Willer A; Riessland-Seifert A; Lebherz-Eichinger D; Fasching P; Ebenbichler C; Kautzky A; Toplak H
Article: JOURNAL OF WOMENS HEALTH. 2022;31(11):1529-1539
Sex and Gender Impact Mental and Emotional Well-Being During COVID-19 Pandemic: A European Countries Experience
Gisinger T; Dev R; Kautzky A; Harreiter J; Raparelli V; Kublickiene K; Herrero MT; Norris CM; Lavoie KL; Pilote L; Kautzky-Willer A
Article: JOURNAL OF AFFECTIVE DISORDERS. 2022;312:225-234
Keywords: Major depressive disorder Antidepressant treatment Noradrenergic and specific serotonergic antidepressant Mirtazapine Mianserin
Fugger G; Bartova L; Fabbri C; Fanelli G; Zanardi R; Dold M; Kautzky A; Rujescu D; Souery D; Mendlewicz J; Zohar J; Montgomery S; Serretti A; Kasper S
Article: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2022;272(4):715-727
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
Fugger G; Bartova L; Fabbri C; Fanelli G; Dold M; Swoboda MMM; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2022;149:37-43
Depressive symptoms as a transdiagnostic mediator of mother-to-infant bonding: Results from a psychiatric mother-baby unit
Hoeflich A; Kautzky A; Slamanig R; Kampshoff J; Unger A
Article: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2022;114:110480
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
Fugger G; Bartova L; Dold M; Fabbri C; Fanelli G; Zanardi R; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2022;25(2):118-127
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
Bartova L; Fugger G; Dold M; Kautzky A; Swoboda MMM; Rujescu D; Zohar J; Souery D; Mendlewicz J; Montgomery S; Fabbri C; Serretti A; Kasper S
Article: NEUROENDOCRINOLOGY. 2022;112(2):130-142
Biological and Psychological Stress Correlates Are Linked to Glucose Metabolism, Obesity, and Gender Roles in Women
Kautzky A; Heneis K; Stengg K; Froehlich S; Kautzky-Willer A
Article: OBESITY SURGERY. 2022;32(1):8-17
Sex-Specific Differences in Mortality of Patients with a History of Bariatric Surgery: a Nation-Wide Population-Based Study
Beiglboeck H; Morth E; Reichardt B; Stamm T; Itariu B; Harreiter J; Hufgard-Leitner M; Fellinger P; Eichelter J; Prager G; Kautzky A; Kautzky-Willer A; Wolf P; Krebs M
Article: NEUROPSYCHIATRIE. 2021;35(4):187-191
Announced assisted suicide in Switzerland: a case report
Vyssoki B; Stich M; Eder-Pissarek E; Jez I; Dobias S; Unger A; Kautzky A; Psota G
Article: EUROPEAN PSYCHIATRY. 2021;64(1):e70
Effects of media stories featuring coping with suicidal crises on psychiatric patients: Randomized controlled trial
Niederkrotenthaler T; Baumgartner J; Kautzky A; Fellinger M; Jahn R; Wippel A; Koch M; Koenig-Castillo D; Hoeflich A; Slamanig R; Topitz A; Wancata J; Till B
Article: JOURNAL OF PERSONALIZED MEDICINE. 2021;11(11):1096
Short Term Caloric Restriction and Biofeedback Enhance Psychological Wellbeing and Reduce Overweight in Healthy Women
Kautzky A; Heneis K; Stengg K; Froehlich S; Kautzky-Willer A
Article: JOURNAL OF PERSONALIZED MEDICINE. 2021;11(10):984
Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years
Leutner M; Kaleta M; Bellach L; Kautzky A; Thurner S; Klimek P; Kautzky-Willer A
Article: DEPRESSION AND ANXIETY. 2021;38(9):896-906
Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
Bartova L; Dold M; Fugger G; Kautzky A; Mitschek MMM; Weidenauer A; Hienert MG; Frey R; Mandelli L; Zohar J; Mendlewicz J; Souery D; Montgomery S; Fabbri C; Serretti A; Kasper S
Article: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2021;110:110285
Melancholic features in major depression-a European multicenter study
Dold M; Bartova L; Fugger G; Kautzky A; Mitschek MMM; Fabbri C; Montgomery S; Zohar J; Souery D; Mendlewicz J; Serretti A; Kasper S
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2021;24(7):542-550
The Influence of Acute SSRI Administration on White Matter Microstructure in Patients Suffering From Major Depressive Disorder and Healthy Controls
Seiger R; Gryglewski G; Kloebl M; Kautzky A; Godbersen GM; Rischka L; Vanicek T; Hienert M; Unterholzner J; Silberbauer LR; Michenthaler P; Handschuh P; Hahn A; Kasper S; Lanzenberger R
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;286:149-157
The Role of Relationship Status in Major Depressive Disorder-Results of the European Group for the Study of Resistant Depression
Bartova L; Dold M; Fugger G; Kautzky A; Mitschek MMM; Weidenauer A; Handschuh PA; Frey R; Mandelli L; Zohar J; Mendlewicz J; Souery D; Montgomery S; Fabbri C; Serretti A; Kasper S
Article: JOURNAL OF PERSONALIZED MEDICINE. 2021;11(5):328
Risk of Typical Diabetes-Associated Complications in Different Clusters of Diabetic Patients: Analysis of Nine Risk Factors
Leutner M; Haug N; Bellach L; Dervic E; Kautzky A; Klimek P; Kautzky-Willer A
Article: MOLECULAR PSYCHIATRY. 2021;26(3):1009-1018
Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET
Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Berroteran-Infante N; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hartmann AM; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Journal article: FRONTIERS IN MEDICINE. 2021;8:608083
Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
Michael L; Caspar M; Alexander K; Michaela K; Stefan T; Peter K; Alexandra K-W
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2021;143(1):36-49
Combining machine learning algorithms for prediction of antidepressant treatment response
Kautzky A; Moller H-J; Dold M; Bartova L; Seemuller F; Laux G; Riedel M; Gaebel W; Kasper S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;41:70-80
Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study
Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S
Article: OBESITY SURGERY. 2020;30(10):3753-3760
Psychopharmacological Medication Has No Influence on Vitamin Status After Bariatric Surgery in Long-term Follow-up
Beiglboeck H; Kautzky A; Fellinger P; Ranzenberger-Haider T; Itariu B; Wrba T; Prager G; Kautzky-Willer A; Wolf P; Krebs M
Article: BMJ OPEN DIABETES RESEARCH & CARE. 2020;8(1):e001430
Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men
Deischinger C; Dervic E; Leutner M; Kosi-Trebotic L; Klimek P; Kautzky A; Kautzky-Willer A
Article: TRANSLATIONAL PSYCHIATRY. 2020;10(1):104
Machine learning classification of ADHD and HC by multimodal serotonergic data
Kautzky A; Vanicek T; Philippe C; Kranz GS; Wadsak W; Mitterhauser M; Hartmann A; Hahn A; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Article: TRANSLATIONAL PSYCHIATRY. 2020;10(1):50
A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping
Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Uher R; Lewis CM; Serretti A
Article: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2019;94:109638
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression
Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
Article: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2019;12:172
Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR
Silberbauer LR; Gryglewski G; Berroteran-Infante N; Rischka L; Vanicek T; Pichler V; Hienert M; Kautzky A; Philippe C; Godbersen GM; Vraka C; James GM; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Hahn A; Lanzenberger R
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29(6):711-719
Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging
Gryglewski G; Kloebl M; Berroteran-Infante N; Rischka L; Balber T; Vanicek T; Pichler V; Kautzky A; Klebermass E-M; Reed MB; Vraka C; Hienert M; James GM; Silberbauer L; Godbersen GM; Unterholzner J; Michenthaler P; Hartenbach M; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hahn A; Hacker M; Kasper S; Lanzenberger R
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29(6):777-785
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study
Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
Article: WIENER KLINISCHE WOCHENSCHRIFT. 2019;131(Suppl 1):186-195
Mental disorders and diabetes mellitus (Update 2019)
Abrahamian H; Kautzky-Willer A; Riessland-Seifert A; Fasching P; Ebenbichler C; Kautzky A; Hofmann P; Toplak H
Article: BRITISH JOURNAL OF PSYCHIATRY. 2019;214(3):159-167
Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis
Gryglewski G; Baldinger-Melich P; Seiger R; Godbersen GM; Michenthaler P; Kloebl M; Spurny B; Kautzky A; Vanicek T; Kasper S; Frey R; Lanzenberger R
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):5
Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
Kautzky A; James GM; Philippe C; Baldinger-Melich P; Kraus C; Kranz GS; Vanicek T; Gryglewski G; Hartmann AM; Wadsak W; Mitterhauser M; Rujescu D; Kasper S; Lanzenberger R
Article: JOURNAL OF CLINICAL PSYCHIATRY. 2019;80(1):17m12090
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression
Dold M; Bartova L; Kautzky A; Porcelli S; Montgomery S; Zohar J; Mendlewicz J; Souery D; Serretti A; Kasper S
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2019;139(1):78-88
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
Kautzky A; Dold M; Bartova L; Spies M; Kranz GS; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Dikeos D; Rujescu D; Kasper S
Article: CEREBRAL CORTEX. 2019;29(1):372-382
Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo
James GM; Gryglewski G; Vanicek T; Berroteran-Infante N; Philippe C; Kautzky A; Nics L; Vraka C; Godbersen GM; Unterholzner J; Sigurdardottir HL; Spies M; Seiger R; Kranz GS; Hahn A; Mitterhauser M; Wadsak W; Bauer A; Hacker M; Kasper S; Lanzenberger R
Article: BRITISH JOURNAL OF PSYCHIATRY. 2019;214(1):36-41
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples
Fabbri C; Kasper S; Kautzky A; Bartova L; Dold M; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Uher R; Lewis CM; Mendlewicz J; Serretti A
Article: FRONTIERS IN AGING NEUROSCIENCE. 2018;10:406
Prediction of Autopsy Verified Neuropathological Change of Alzheimer's Disease Using Machine Learning and MRI
Kautzky A; Seiger R; Hahn A; Fischer P; Krampla W; Kasper S; Kovacs GG; Lanzenberger R
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2018;28(12):1305-1313
Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study
Dold M; Bartova L; Kautzky A; Serretti A; Porcelli S; Souery D; Mendlewicz J; Montgomery S; Zohar J; Kasper S
Article: TRANSLATIONAL PSYCHIATRY. 2018;8(1):198
Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy
Spies M; James GM; Vraka C; Philippe C; Hienert M; Gryglewski G; Komorowski A; Kautzky A; Silberbauer L; Pichler V; Kranz GS; Nics L; Balber T; Baldinger-Melich P; Vanicek T; Spurny B; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R; Winkler D
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2018;28(6):752-760
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)
Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2018;21(6):539-549
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
Dold M; Bartova L; Fugger G; Kautzky A; Souery D; Mendlewicz J; Papadimitriou GN; Dikeos D; Ferentinos P; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
Article: BRAIN STRUCTURE & FUNCTION. 2018;223(3):1369-1378
Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity
Hahn A; Gryglewski G; Nics L; Rischka L; Ganger S; Sigurdardottir H; Vraka C; Silberbauer L; Vanicek T; Kautzky A; Wadsak W; Mitterhauser M; Hartenbach M; Hacker M; Kasper S; Lanzenberger R
Article: JOURNAL OF CLINICAL PSYCHIATRY. 2018;79(1):16m11385
Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample
Kautzky A; Dold M; Bartova L; Spies M; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Kasper S
Article: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2018;81:203-210
Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance
Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(7):625-632
The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study
Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
Article: TRANSLATIONAL PSYCHIATRY. 2017;7(6):e1150
The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning
Kautzky A; James GM; Philippe C; Baldinger-Melich P; Kraus C; Kranz GS; Vanicek T; Gryglewski G; Wadsak W; Mitterhauser M; Rujescu D; Kasper S; Lanzenberger R
Article: NEUROIMAGE. 2017;149:23-32
Simple and rapid quantification of serotonin transporter binding using [¹¹C] DASB bolus plus constant infusion
Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroteran-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
Article: JOURNAL OF CLINICAL PSYCHIATRY. 2017;78(2):215-222
A New Prediction Model for Evaluating Treatment-Resistant Depression
Kautzky A; Baldinger-Melich P; Kranz GS; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
Article: HUMAN BRAIN MAPPING. 2017;38(2):792-802
Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET
Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Hoeflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
Article: CEREBRAL CORTEX. 2017;27(1):117-130
Association of Protein Distribution and Gene Expression Revealed by PET and Post-Mortem Quantification in the Serotonergic System of the Human Brain
Komorowski A; James GM; Philippe C; Gryglewski G; Bauer A; Hienert M; Spies M; Kautzky A; Vanicek T; Hahn A; Traub-Weidinger T; Winkler D; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2016;26(12):1960-1971
Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study
Dold M; Kautzky A; Bartova L; Rabl U; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
Article: JOURNAL OF NUCLEAR MEDICINE. 2016;57(12):1933-1940
Quantification of Task-Specific Glucose Metabolism with Constant Infusion of ¹⁸F-FDG
Hahn A; Gryglewski G; Nics L; Hienert M; Rischka L; Vraka C; Sigurdardottir H; Vanicek T; James GM; Seiger R; Kautzky A; Silberbauer L; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R
Article: PSYCHONEUROENDOCRINOLOGY. 2016;74:371-379
Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration
Seiger R; Hahn A; Hummer A; Kranz GS; Ganger S; Woletz M; Kraus C; Sladky R; Kautzky A; Kasper S; Windischberger C; Lanzenberger R
Article: HUMAN BRAIN MAPPING. 2016;37(3):884-895
Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET
Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Article: JOURNAL OF AFFECTIVE DISORDERS. 2016;189:224-232
Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study
Balestri M; Calati R; Souery D; Kautzky A; Kasper S; Montgomery S; Zohar J; Mendlewicz J; Serretti A
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015;25(4):441-453
The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression
Kautzky A; Baldinger P; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
Article: CARDIOVASCULAR DIABETOLOGY. 2013;12:78
Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study
Kautzky-Willer A; Stich K; Hintersteiner J; Kautzky A; Kamyar MR; Saukel J; Johnson J; Lemmens-Gruber R
Journal article: JOURNAL OF PSYCHOSOMATIC RESEARCH. 1993;37(8):831-841
HORMONAL AND BLOOD-GLUCOSE RESPONSIVENESS AS AN INDICATOR OF SPECIFIC EMOTIONAL AROUSAL IN TYPE-1 DIABETICS
SACHS G; SPIESS K; MOSER G; KAUTZKY A; LUGER A; PIETSCHMANN P; SCHERNTHANER GS; PRAGER R
Journal article: THROMBOSIS RESEARCH. 1992;66(6):735-743
LABORATORY MONITORING OF THROMBOPROPHYLAXIS WITH LOW-MOLECULAR-WEIGHT AND STANDARD HEPARIN
VUKOVICH T; PROIDL S; TEUFELSBAUER H; KAUTZKY A; ERLACHER L; LUGER A; WEISSEL M
Journal article: STRAHLENTHERAPIE. 1970;140(6):630-&
X-RAY IRRADIATION OF VERRUCA JUVENILIS REGARDING ITS PLANTAR FORM
KAUTZKY A
Visa fler

Alla övriga publikationer

Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2025;28:i65
LOCKDOWN-ASSOCIATED CHANGES IN THE DEFAULT MODE NETWORK IN DEPRESSION AND HEALTHY INDIVIDUALS DURING THE COVID-19 PANDEMIC IN AUSTRIA
Unterholzner J; Elbau IG; Kautzky A; Reed MB; Popper V; Spurny-Dworak B; Bukhari H; Stoehrmann P; Kloebl M; Muehlberger A; Frey R; Wechsler TF; Rujescu D; Lanzenberger R; Vanicek T
Preprint: ARXIV. 2023
Unraveling cradle-to-grave disease trajectories from multilayer comorbidity networks
Dervić E; Sorger J; Yang L; Leutner M; Kautzky A; Thurner S; Kautzky-Willer A; Klimek P
Letter: AMERICAN JOURNAL OF PSYCHIATRY. 2022;179(9):687
Psychotherapy's Role for Treatment-Resistant Depression?
Bartova L; Fugger G; Dold M; Kautzky A; Rujescu D; Kasper S
Review: ACTA PSYCHIATRICA SCANDINAVICA. 2022;145(1):6-28
Neonatal outcome and adaption after in utero exposure to antidepressants: A systematic review and meta-analysis
Kautzky A; Slamanig R; Unger A; Hoeflich A
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2021;46(SUPPL 1):198
Impact of Body Mass Index on Clinical Outcomes in Major Depressive Disorder - Results From the European GSRD Database
Kraus C; Kautzky A; Kadriu B; Deng Z-D; Bartova L; Spies M; Zarate C; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Kasper S
Conference publication: DIABETOLOGIA. 2021;64(SUPPL 1):41
Sex-specific differences in patients deceased after bariatric surgery: a retrospective, registry analysis
Beiglboeck H; Moerth E; Reichardt B; Stamm T; Itariu B; Harreiter J; Hufgard-Leitner M; Fellinger P; Eichelter J; Prager G; Kautzky A; Kautzky-Willer A; Wolf P; Krebs M
Corrigendum: FRONTIERS IN MEDICINE. 2021;8:677866
Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment (vol 8, 608083, 2021)
Leutner M; Matzhold C; Kautzky A; Kaleta M; Thurner S; Klimek P; Kautzky-Willer A
Conference publication: WIENER KLINISCHE WOCHENSCHRIFT. 2020;132:S338
Impact of Psychotropic Drugs on Vitamin Deficiency States after bariatric Surgery
Beiglboeck H; Kautzky A; Fellinger P; Ranzenberger-Haider T; Itariu B; Wrba T; Prager G; Kautzky-Willer A; Wolf P; Krebs M
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;31:S55
Twelve weeks of antidepressant treatment did not alter brain structure in depressive patients -A 3T-MR investigation
Vanicek T; Grygleweski G; Seiger R; Kautzky A; Manfred K; Mathis G; Jakob U; Lukas R; Paul M; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S58-S59
A genetic predictor of treatment-resistant depression using exome sequencing and genome-wide genotyping
Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Dikeos D; Rujescu D; Mendlewicz J; Lewis C; Serretti A
Conference publication: WIENER KLINISCHE WOCHENSCHRIFT. 2019;131:S469
Gender gap in the diagnosis of depression more prevalent in type 2 diabetes mellitus patients than non-diabetics in Austrian population from 2003 until 2014
Deischinger C; Dervic E; Kosi-Trebotic L; Kautzky A; Klimek P; Kautzky-Willer A
Corrigendum: TRANSLATIONAL PSYCHIATRY. 2019;9(1):246
Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression (vol 9, 5, 2019)
Kautzky A; James GM; Philippe C; Baldinger-Melich P; Kraus C; Kranz GS; Vanicek T; Gryglewski G; Hartmann AM; Hahn A; Wadsak W; Mitterhauser M; Rujescu D; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S92
PREDICTION OF TREATMENT-RESISTANT DEPRESSION USING EXOME SEQUENCE AND GENOME-WIDE DATA
Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Ferentinos P; Rujescu D; Mendlewicz J; Lewis C; Serretti A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S207
HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Fanelli G; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
Review: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2019;20(6):427-448
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice
Bartova L; Dold M; Kautzky A; Fabbri C; Spies M; Serretti A; Souery D; Mendlewicz J; Zohar J; Montgomery S; Schosser A; Kasper S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2019;39:549-550
A genetic polymorphism of HTR1B and serotonin transporter binding measured by PET enable accurate machine learning cassification of MDD and HC
Kautzky A; James GM; Philippe C; Gryglewski G; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S302-S303
Segmentation of hippocampal subfields and nuclei of the amygdala with major depressive disorder and healthy controls - preliminary findings
Vanicek T; Seiger R; Gryglewski G; Kautzky A; Manfred K; Godbersen M; Rischka L; James GM; Silberbauer L; Michenthaler P; Kranz GS; Hahn A; Winkler D; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S364-S365
A genome-wide association study of treatment-resistant depression and meta-analysis with STAR*D
Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Mendlewicz J; Serretti A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S61-S62
Clinical predictors of treatment resistant depression: Replication results from the European multicenter study
Kautzky A; Dold M; Bartova L; Spies M; Kranz GS; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Dikeos D; Rujescu D; Kasper S
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S602-S603
Parcellation of the cortical serotonergic neuro-transmitter system using positron emission tomography and FreeSurfer
James GM; Gryglewski G; Vanicek T; Berroteran-Infante N; Philippe C; Kautzky A; Nics L; Vraka C; Godbersen GM; Unterholzner J; Sigurdardottir HL; Spies M; Seiger R; Kranz GS; Hahn A; Mitterhauser M; Wadsak W; Bauer A; Hacker M; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S140-S141
Norepinephrine transporter methylation profile and association with symptoms of ADHD and in vivo NET expression as measured by PET
Sigurdardottir H; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Berroteran-Infante N; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hartmann A; Hacker M; Rujescu D; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S934-S935
WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION
Serretti A; Fabbri C; Albani D; Kasper S; Zohar J; Souery D; Kautzky A; Montgomery S; Mendlewicz J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S867
PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE
Fabbri C; Corponi F; Albani D; Forloni G; Kasper S; Zohar J; Souery D; Montgomery S; Mantovani V; Mendlewicz J; Kautzky A; Raimondi I; Serretti A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:1166-1167
AN EXOME SEQUENCING STUDY IN TREATMENT-RESISTANT DEPRESSION
Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Mendlewicz J; Lewis C; Serretti A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:1246
A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES
Fabbri C; Kasper S; Kautzky A; Bartova L; Dold M; Zohar J; Souery D; Albani D; Raimondi I; Dikeos D; Rujescu D; Uher R; Lewis C; Mendlewicz J; Serretti A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2018;28:S62-S63
Pleiotropic genes in psychiatry: calcium channels and the stress-related FKBP5 gene in antidepressant resistance
Corponi F; Fabbri C; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S707
Influence of serotonergic gene variants on serotonin transporter binding in ADHD
Sigurdardottir HL; Kranz GS; Vanicek T; James GM; Philippe C; Kautzky A; Papageorgiou K; Mitterhauser M; Wadsak W; Rujescu D; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S1030-S1031
Classification and prediction of neuropathological change of Alzheimer's disease using machine learning and MRI
Kautzky A; Seiger R; Hahn A; Fischer P; Krampla W; Kasper S; Kovacs G; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S805-S806
Dynamic connectivity analysis of selective serotonin reuptake inhibitor effects, a pharmacological PET/MR study
Gryglewski G; Hahn A; Berroteran-Infante N; Kloebl M; Klebermass EM; Hienert M; Pichler V; Vanicek T; Nics L; Riscka L; Kautzky A; James GM; Silberbauer L; Hartenbach M; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S801-S802
Cortical monoamine oxidase - a distribution in seasonal affective disorder compared to healthy controls
James GM; Seiger R; Spies M; Vraka C; Philippe C; Hienert M; Gryglewski G; Komorowski A; Kautzky A; Silberbauer L; Pichler V; Kranz G; Nics L; Balber T; Baldinger-Melich P; Vanicek T; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R; Winkler D
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:162-163
An attenuation correction approach based on segmentation of structural images for hybrid PET/MRI systems
Rischka L; Hahn A; Berroteran-Infante N; Gryglewski G; Philippe C; Kloebl M; James GM; Kautzky A; Vanicek T; Wadsak W; Mitterhauser M; Traub-Weidinger T; Hacker M; Kasper S; Lanzenberger R
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:156
Simultaneous PET/MR imaging of task-specific changes in glucose metabolism, functional connectivity and white matter microstructure
Hahn A; Gryglewski G; Nics L; Rischka L; Ganger S; Sigurdardottir H; Silberbauer L; Vanicek T; Kautzky A; Wadsak W; Mitterhauser M; Hartenbach M; Hacker M; Kasper S; Lanzenberger R
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:141-142
[¹¹C]DASB bolus plus constant infusion to rapidly quantify serotonin transporter binding
Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroteran-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
Conference publication: EUROPEAN PSYCHIATRY. 2017;41:S367
Prescribing patterns of psychiatric drugs in major depressive disorder - Findings from a large European multicenter, cross-sectional study
Dold M; Kautzky A; Bartova L; Rabl U; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2016;26:S417-S418
Epidemiology of psychopharmacological options in unipolar major depression in European tertiary psychiatric treatment centers
Bartova L; Dold M; Kautzky A; Rabl U; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2016;26:S317
Attenuation of habenula-default mode network connectivity by selective serotonin reuptake inhibitors, a pharmacological hybrid PET/MR study
Gryglewski G; Kloebl M; Nics L; Hahn A; Philippe C; Rischka L; Kautzky A; Hartenbach M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger L
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2016;26:S317-S318
Interregional associations of NET binding in attention deficit/hyperactivity disorder; assessed with (S,S)-[¹⁸F]FMeNER-D2
Vanicek T; Berroteran-Infante N; James G; Kautzky A; Hahn A; Kranz G; Sigurdardottir H; Hoeflich A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2016;19:249-250
Interregional Correlations of SERT in Attention Deficit/Hyperactivity Disorder compared to Healthy Controls; Investigated with PET and [11C]DASB
Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Hoeflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2016;19:114-115
Light exposure and seasonal variation of the serotonin degrading enzyme monoamine oxidase A in the healthy human brain revealed by PET
Hienert M; Spies M; Vraka C; James GM; Hahn A; Nics L; Philippe C; Gryglewski G; Baldinger-Melich P; Kautzky A; Komorowski A; Vanicek T; Winkler-Pjrek E; Traub-Weidinger T; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Winkler D; Lanzenberger R
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2016;19:107-108
Hybrid PET/MR imaging of serotonin transporter occupancy and brain activation to elucidate the mechanism of action of selective serotonin reuptake inhibitors
Gryglewski G; Kautzky A; Philippe C; Vanicek T; Hahn A; Klebermass E; Rischka L; Kloebl M; Vraka C; Ganger S; Nics L; Hartenbach M; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2016;19:72-73
Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers
Bartova L; Dold M; Kautzky A; Rabl U; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2016;19:77
An update on prediction of treatment outcome in treatment resistant depression
Kautzky A; Dold M; Gryglewski G; Baldinger-Melich P; Spies M; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:123-124
SEASONAL VARIATION OF MONOAMINE OXIDASE A QUANTIFIED WITH [11C]HARMINE AND POPULATION-BASED INPUT FUNCTIONS
Hahn A; Winkler D; Vraka C; Nics L; Philippe C; James GM; Gryglewski G; Hienert M; Baldinger P; Kautzky A; Spies M; Komorowski A; Vanicek T; Winkler-Pjrek E; Traub-Weidinger T; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015;25:S304
Cerebral monoamine oxidase A distribution volume in seasonal affective disorder
Baldinger P; James GM; Spies M; Kranz GS; Hienert M; Kautzky A; Gryglewski G; Kasper S; Lanzenberger R; Winkler D
Review: DIABETOLOGIA. 2015;58(2):242-254
Sex-specific differences in diabetes prevention: a systematic review and meta-analysis
Glechner A; Harreiter J; Gartlehner G; Rohleder S; Kautzky A; Tuomilehto J; Van Noord M; Kaminski-Hartenthaler A; Kautzky-Willer A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S399
The combined effect of genetic polymorphisms and clinical parameters on treatment response and resistance in major depressive disorder
Kautzky A; Calati R; Baldinger P; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
Conference publication: DIABETOLOGIA. 2014;57:S120
Sex-specific differences in prevention of type 2 diabetes mellitus: a systematic review and meta-analysis
Harreiter J; Glechner A; Gartlehner G; Kautzky A; Rohleder S; Van Noord M; Kaminski-Hartenthaler A; Tuomilehto J; Kautzky-Willer A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S65-S66
Genetic variants in ST8SIA2 gene influence treatment outcome in treatment resistant depression: a European multicenter study
Kautzky A; Baldinger P; Calati R; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
Conference publication: WIENER KLINISCHE WOCHENSCHRIFT. 2013;125:S10
Gender Specific Differences in preventive Lifestyle-Modifications with Prediabetes: Systematic Overview
Harreiter J; Glechner A; Rohleder S; Kautzky A; Kaminski-Hartenthaler A; Gartlehner G; Kautzky-Willer A
Visa fler

Anställningar

board-certified psychiatrist, Psychiatry and Psychotherapy, Clinical Division of Social Psychiatry, Medical University of Vienna, 2013-
Anknuten till Forskning, Klinisk neurovetenskap, Karolinska Institutet, 2023-2026

Artiklar

Alla övriga publikationer

Anställningar

Nyheter från KI

Kalenderhändelser från KI